Psychoactive Substances:Transforming the Paradigm for Treating Mental Health Disorders in the Post‑Pandemic Era  

作　　者：Haojiang Zhai Yibo Wang Xiaohui Wang 

机构地区：[1]Laboratory of Chemical Biology,Changchun Institute of Applied Chemistry,Chinese Academy of Sciences,Changchun 130022,China [2]School of Applied Chemistry and Engineering,University of Science and Technology of China,Hefei 230026,China

出　　处：《Neuroscience Bulletin》2025年第3期536-538,共3页神经科学通报(英文版)

基　　金：supported by the National Natural Science Foundation of China(T2241028);STI2030-Major Projects[2021ZD0203000(2021ZD0203003)].

摘　　要：Mental health disorders have emerged as a critical global health challenge,profoundly impacting individuals,communities,and societies worldwide.The prevalence of mental health problems has been steadily increasing,with~1 in 8 people,equivalent to 970 million individuals suffering from a mental disorder in 2019(https://vizhub.healthdata.org/gbd-results).Anxiety and depressive disorders are predominant,contributing significantly to the burden of mental health issues,according to the World Health Organization.The COVID-19 pandemic has further exacerbated this situation.It led to a notable upsurge in anxiety and major depressive disorders in 2020.Estimates indicate a 26%rise in anxiety and a 28%increase in depression within that year(https://www.who.int/publications/i/item/WHO-2019-nCoVSci_Brief-Mental_health-2022.1)[1].

关 键 词：psychoactive substances depressive disorders post pandemic era mental health disorders mental disorder global health challenge mental health problems ANXIETY 

分 类 号：R749[医药卫生—神经病学与精神病学]